| Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
| HY-P0276 |
GIP, human |
Agonist |
99.94% |
Unkown |
| HY-P10138 |
human GIP(3-30), amide |
Antagonist |
99.76% |
Unkown |
| HY-P3247 |
[D-Ala2]-GIP (human) |
Agonist |
99.95% |
Unkown |
| HY-P0276A |
GIP, human TFA |
Agonist |
99.15% |
Unkown |
| HY-P10735 |
GIP (mouse) |
|
98.79% |
Unkown |
| HY-P2542 |
GIP (3-42), human |
Antagonist |
99.75% |
Unkown |
| HY-P10138A |
human GIP(3-30), amide TFA |
Antagonist |
96.90% |
Unkown |
| HY-P2080B |
GIP (1-30) amide,human acetate |
Agonist |
99.27% |
Unkown |
| HY-P1434 |
[Pro3]-GIP (mouse) |
Antagonist |
98.84% |
Unkown |
| HY-P11285A |
LAGIPRA peptide TFA |
Agonist |
98.65% |
Unkown |
| HY-P3579 |
Gastric Inhibitory Peptide, porcine |
|
99.12% |
Unkown |
| HY-P10302A |
GLP-1R/GIPR agonist-1 (soduim) |
Agonist |
98.24% |
Unkown |
| HY-P11321A |
IUB0271 hydrochloride |
|
98.67% |
Unkown |
| HY-P3584A |
(Pro3) GIP, human TFA |
|
99.89% |
Unkown |
| HY-P11666 |
Brenipatide |
Agonist |
99.29% |
Unkown |
| HY-P2541A |
GIP (1-30) amide, porcine TFA |
Agonist |
99.14% |
Unkown |
| HY-P10959A |
Macupatide acetate |
Agonist |
99.95% |
Unkown |
| HY-P10929 |
Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH |
|
99.31% |
Unkown |
| HY-P11271A |
Ribupatide TFA |
Agonist |
99.75% |
Unkown |
| HY-13749AS |
Sitagliptin-d4 phosphate |
Inhibitor |
99.48% |
Unkown |
| HY-P11237 |
Enicepatide |
Agonist |
98.16% |
Unkown |
| HY-P3580A |
Acetyl Gastric Inhibitory Peptide (human) TFA |
|
99.70% |
Unkown |
| HY-13749S1 |
Sitagliptin-d4 hydrochloride |
Inhibitor |
99.36% |
Unkown |
| HY-153476A |
GIP/GLP-1 dual receptor agonist-1 sodium |
Agonist |
98.33% |
Unkown |
| HY-P10591 |
Olatorepatide |
|
99.35% |
Unkown |
| HY-P10302 |
GLP-1R/GIPR agonist-1 |
Agonist |
/ |
Unkown |
| HY-P10965 |
Zovaglutide |
Agonist |
/ |
Unkown |
| HY-P11271 |
Ribupatide |
Agonist |
98.74% |
Unkown |
| HY-P2080C |
GIP (1-30)-Myr |
Agonist |
/ |
Unkown |
| HY-P3255 |
DA-JC4 |
Agonist |
99.27% |
Unkown |
| HY-P3584 |
(Pro3) GIP, human |
Agonist |
99.79% |
Unkown |
| HY-103545 |
GIP (1-39) |
Agonist |
/ |
Unkown |
| HY-120493 |
(rel)-AM-6226 |
Agonist |
/ |
Unkown |
| HY-120493A |
AM-6226 |
Agonist |
/ |
Unkown |
| HY-13749S2 |
Sitagliptin-d4 |
Inhibitor |
/ |
Unkown |
| HY-153476 |
GIP/GLP-1 dual receptor agonist-1 |
Agonist |
/ |
Unkown |
| HY-162513 |
DPP-4-IN-10 |
Inhibitor |
/ |
Unkown |
| HY-171302 |
GLP-1R/GIPR agonist-2 |
Agonist |
/ |
Unkown |
| HY-E70397A |
Dipeptidyl Peptidase IV, Porcine Kidney |
|
/ |
Unkown |
| HY-P10952 |
Astepatide |
Agonist |
/ |
Unkown |
| HY-P10972 |
GIP (22-51) human |
|
/ |
Unkown |
| HY-P11233 |
Acmopatide |
Agonist |
/ |
Unkown |
| HY-P11270 |
Relsipatide |
Agonist |
/ |
Unkown |
| HY-P11285 |
LAGIPRA peptide |
Agonist |
/ |
Unkown |
| HY-P11321 |
IUB0271 |
|
/ |
Unkown |
| HY-P11674 |
Zantrutide |
Agonist |
/ |
Unkown |
| HY-P1433 |
[Pro3]-GIP (Rat) |
Agonist |
/ |
Unkown |
| HY-P2080 |
GIP (1-30) amide,human |
Agonist |
/ |
Unkown |
| HY-P2541 |
GIP (1-30) amide, porcine |
Agonist |
/ |
Unkown |
| HY-P3577 |
[Tyr0] Gastric Inhibitory Peptide (23-42), human |
|
/ |
Unkown |
| HY-P3578 |
Gastric Inhibitory Polypeptide (1-30), porcine |
Modulator |
/ |
Unkown |
| HY-P3580 |
Acetyl Gastric Inhibitory Peptide (human) |
|
/ |
Unkown |
| HY-RS01726 |
C1QTNF1 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS05434 |
GIP Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS05535 |
GNAI2 Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-13749S3 |
Sitagliptin-d6 |
Inhibitor |
/ |
Unkown |
| HY-174832 |
DPP-4-IN-16 |
Inhibitor |
/ |
Unkown |
| HY-RS16530 |
Gip Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS22961 |
Gip Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |